beinaglutide

Home
Ligands
beinaglutide

GtoPdb Ligand ID: 12863

Synonyms: Feisumei®

beinaglutide is an approved drug (China NMPA (2023))

Compound class: Peptide or derivative

Comment: Beinaglutide is a glucagon-like peptide-1 (GLP-1) analogue [2-3]. To our knowledge the peptide sequence and/or any anti-proteolytic modifications in beinaglutide have not been disclosed.

References
1. Gao L, Huang H, Zhang L, Zhang N, Fu Y, Zhu D, Bi Y, Feng W. (2022) Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients. Exp Clin Endocrinol Diabetes, 130 (6): 358-367. [PMID:34856624]
2. Wang G, Wu P, Qiu Y, Dong X, Wang Y, Chi Y, Zhang F, Li Y, Zhang J, Huang Z et al.. (2021) Effect of beinaglutide treatment on weight loss in Chinese patients with type 2 diabetes mellitus and overweight/obesity. Arch Endocrinol Metab, 65 (4): 421-427. [PMID:34283904]
3. Wang JY, Wang QW, Yang XY, Yang W, Li DR, Jin JY, Zhang HC, Zhang XF. (2023) GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach. Front Endocrinol (Lausanne), 14: 1085799. [PMID:36843578]

References

1. Gao L, Huang H, Zhang L, Zhang N, Fu Y, Zhu D, Bi Y, Feng W. (2022)
Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients.
Exp Clin Endocrinol Diabetes, 130 (6): 358-367. [PMID:34856624]

2. Wang G, Wu P, Qiu Y, Dong X, Wang Y, Chi Y, Zhang F, Li Y, Zhang J, Huang Z et al.. (2021)
Effect of beinaglutide treatment on weight loss in Chinese patients with type 2 diabetes mellitus and overweight/obesity.
Arch Endocrinol Metab, 65 (4): 421-427. [PMID:34283904]

3. Wang JY, Wang QW, Yang XY, Yang W, Li DR, Jin JY, Zhang HC, Zhang XF. (2023)
GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach.
Front Endocrinol (Lausanne), 14: 1085799. [PMID:36843578]